In conclusion, we demonstrated that propofol inhibits the stemness and EMT of colon cancer cells by downregulating the SIRT1 and the Wnt/β-catenin and AKT/mTOR signaling pathways. The gene discussed is AKT1; the disease is malignant colon neoplasm.